Cadre Holdings, Inc. (CDRE) stock intrinsic value fair value estimate & owner earnings analysis

Cadre Holdings makes safety and survivability equipment for police, corrections, military and nuclear customers: Safariland body armor and duty gear (holsters, belts), Med-Eng bomb-disposal suits, robots and blast sensors, and, since 2024-2025, nuclear-safety products from the Alpha Safety and Zircaloy (Carr's Engineering) acquisitions. In 2025 it sold $610 million: about 49% to U.S. state and local agencies, 17% to U.S. federal agencies, 8% commercial and 24% international. The company says over 60% of its product sales follow customary or mandated replacement cycles of five to ten years, which is the main reason its earnings have been steady. How we measured earnings. We start from cash generated by operations, strip out swings in working capital, charge stock-based pay as a real cost, and deduct the capital spending needed to maintain the plants (capex is only about 1% of sales). On that basis owner earnings were $47.3 million in 2023, $55.0 million in 2024 and $61.2 million in 2025 ($1.25, $1.36 and $1.41 per diluted share). Our own rebuild of those figures from net income plus non-cash charges matches exactly. Amortization of acquired intangibles (about $9 million a year) is added back as a sunk acquisition cost. Because Cadre carries debt, we value the business before interest (adding back cash interest of $14.4 million in 2024 and $17.8 million in 2025) and then subtract what it owes. We anchor on the median of 2024-2025, about $74 million a year of pre-interest cash flow. Earlier years are left out: before the late-2021 IPO the company carried a much heavier debt load and paid almost no cash tax because of past losses, 2022 carried an unusually large $31.9 million stock-compensation charge, and the Alpha Safety purchase in 2024 changed the mix of the business. Recent growth has come from acquisitions, not from the existing business. In 2025, sales rose $42.7 million, but Zircaloy alone added $49.2 million; duty gear grew $19.0 million while bomb-disposal products fell $15.5 million and existing nuclear products also declined. Owner earnings rose 11% in dollars in 2025, and 3.4% per share. We assume 2% growth in year one of the base case, below both numbers, because the acquisition-driven jump is not repeatable on its own. We do not assume any future acquisitions. Cadre has bought companies every year or two (Cyalume 2022, ICOR and Alpha Safety 2024, Zircaloy 2025, TYR 2026), but those deals were paid for with borrowing and a 2024 share sale, and several were large compared with the company's annual cash flow. That makes them bets, not a routine the business pays for out of its own cash. TYR Tactical, bought in January 2026 for about $174 million ($150 million cash plus $24 million of stock), is not in the historical earnings, and Cadre has not published TYR's standalone profits. Rather than guess, we count TYR at its purchase price in the base case: no value created, none destroyed. TYR brings armor, plate carriers and vests, with about two-thirds of its revenue outside the U.S., mostly in Europe. Base case: pre-interest cash flow grows 2% a year for ten years. That is below the roughly 6% a year sales growth from 2020 to 2023 (which included the Cyalume acquisition), and it reflects price increases and replacement cycles, not new markets. After year ten, cash flow stays flat indefinitely. The reason: the Safariland and Med-Eng franchises rest on certified products (body armor built to National Institute of Justice standards), an installed base of bomb suits in over 100 countries, and customer relationships many of which exceed 15 years. Nothing beyond that is assumed. The business is worth about $1.62 billion ($37.36 per share), it owes about $348 million ($8.03 per share), and the difference is $29.33 per share. Bear case: the declines already visible in bomb-disposal and legacy nuclear products continue, and pressure on state and local budgets cuts cash flow 5% a year for three years, to about $64 million. It stays there to year ten and then shrinks 3% a year as acquired customer relationships and product lines erode. TYR is worth half its price. The first quarter of 2026 is the evidence here: operating income fell to $7.5 million from $13.6 million a year earlier, even with TYR's added sales. The business is worth about $948 million ($21.85 per share), it owes $348 million ($8.03), and the difference is $13.82 per share. Even in this case, cash flow covers interest of roughly $20-25 million comfortably. Bull case: the pricing power and duty-gear demand the company showed in 2025 continue, and cash flow grows 4% a year for ten years before holding flat. TYR earns more than it cost; the June 2026 quarter, with operating income of $22.5 million against $14.7 million a year earlier, is the first sign of that, so we value TYR at 1.3 times its price. The business is worth about $1.92 billion ($44.22 per share), it owes $348 million ($8.03), and the difference is $36.19 per share. Debt. At June 30, 2026 Cadre owed about $374 million under its bank facilities, plus about $3 million of finance leases and $5 million of estimated earn-out payments for the ICOR acquisition. We count $34 million of its $54 million cash as surplus. The bank loans float at SOFR plus 1.5-2.5%, close to our 6% discount rate, so we make no cost-of-debt adjustment. All the facilities mature on December 20, 2029. The loans require net debt of no more than 3.5 times trailing earnings. In the base and bull cases, cash flow keeps Cadre inside that limit. In the bear case, leverage would sit near it. That could restrict dividends and acquisitions, but with cash flow well above interest it is unlikely to wipe out shareholders. Further debt-funded acquisitions are the main thing that could push leverage toward the limit. What would make this wrong: a sustained fall in police and federal equipment budgets, TYR turning out to be a poor purchase, or more large acquisitions financed with debt or new shares that fail to earn their cost. The company also pays related-party fees, including $1.0 million connected to the Zircaloy deal. TYR's separate contribution to 2026 results could not be isolated from the reported figures.